CD74 : A new candidate target for the immunotherapy of B-cell neoplasmsSTEIN, Rhona; MATTES, M. Jules; CARDILLO, Thomas M et al.Clinical cancer research. 2007, Vol 13, Num 18, issn 1078-0432, 5556s-5563s, 2Conference Paper

Thérapie ciblée en oncologie mieux que des promesses, de nouveaux espoiresLONGUEVILLE, J.Louvain médical. 2007, Vol 126, Num 1, pp 39-43, issn 0024-6956, 5 p.Article

Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactionsAKATSUKA, Yoshiki; MORISHIMA, Yasuo; KUZUSHIMA, Kiyotaka et al.Cancer science. 2007, Vol 98, Num 8, pp 1139-1146, issn 1347-9032, 8 p.Article

Hypereosinophilic syndrome and molecularly targeted therapyMARTINELLI, Giovanni; RONDONI, Michela; OTTAVIANI, Emanuela et al.Seminars in hematology. 2007, Vol 44, Num 2, issn 0037-1963, S4-S16, SUP2Article

Targeted therapy for inherited GPI deficiencyALMEIDA, Antonio M; MURAKAMI, Yoshiko; BAKER, Alastair et al.The New England journal of medicine. 2007, Vol 356, Num 16, pp 1641-1647, issn 0028-4793, 7 p.Article

DNA methylation as a therapeutic target in cancerISSA, Jean-Pierre J.Clinical cancer research. 2007, Vol 13, Num 6, pp 1634-1637, issn 1078-0432, 4 p.Article

Novel treatment strategies for malignant melanoma : A new beginning?KASPER, Bernd; D'HONDT, Veronique; VEREECKEN, Pierre et al.Critical reviews in oncology/hematology. 2007, Vol 62, Num 1, pp 16-22, issn 1040-8428, 7 p.Article

Emerging targeted therapies for breast cancerARNEDOS, Monica; SEIDMAN, Andrew D.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vii, 321-340 [21 p.]Article

Important therapeutic targets in chronic myelogenous leukemiaKANTARJIAN, Hagop M; GILES, Francis; QUINTAS-CARDAMA, Alfonso et al.Clinical cancer research. 2007, Vol 13, Num 4, pp 1089-1097, issn 1078-0432, 9 p.Article

Toll-like receptor 3 expressed by melanoma cells as a target for therapy?SALAUN, Bruno; LEBECQUE, Serge; MATIKAINEN, Sampsa et al.Clinical cancer research. 2007, Vol 13, Num 15, pp 4565-4574, issn 1078-0432, 10 p., 1Article

Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failureFRAGASSO, G.International journal of clinical practice (Esher). 2007, Vol 61, Num 4, pp 603-610, issn 1368-5031, 8 p.Article

Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylateKOSMIDER, O; DENIS, N; DUBREUIL, P et al.Oncogene (Basingstoke). 2007, Vol 26, Num 26, pp 3904-3908, issn 0950-9232, 5 p.Article

La protéine MUC1, cible thérapeutique en oncologie = MUC1, a therapeutic target in oncologyLIMACHER, Jean-Marc; ACRES, Bruce.Bulletin du cancer. 2007, Vol 94, Num 3, pp 253-257, issn 0007-4551, 5 p.Article

Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapyEKLUND, Kari K.Immunological reviews. 2007, Vol 217, pp 38-52, issn 0105-2896, 15 p.Article

Chemokines and atherosclerotic plaque progression: Towards therapeutic targeting?KRAAIJEVELD, A. O; DE JAGER, S. C. A; VAN BERKEL, T. J. C et al.Current pharmaceutical design. 2007, Vol 13, Num 10, pp 1039-1052, issn 1381-6128, 14 p.Article

Hypoxia-inducible factor 1 as a possible target for cancer chemopreventionLOPEZ-LAZARO, Miguel.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 12, pp 2332-2335, issn 1055-9965, 4 p.Article

The mesenchyme in cancer therapy as a target tumor component, effector cell modality and cytokine expression vehicle : Pro-inflammatory cytokines in cancerZIPORI, Dov.Cancer metastasis reviews. 2006, Vol 25, Num 3, pp 459-467, issn 0167-7659, 9 p.Article

Molecularly targeted therapy for malignant gliomaSATHOMSUMETEE, Sith; REARDON, David A; DESJARDINS, Annick et al.Cancer. 2007, Vol 110, Num 1, pp 13-24, issn 0008-543X, 12 p.Article

Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor modelsJIA, Li-Jun; WEI, Dong-Ping; SUN, Qi-Ming et al.Cancer science. 2007, Vol 98, Num 7, pp 1107-1112, issn 1347-9032, 6 p.Article

Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient micePIERCE, Elizabeth M; CARPENTER, Kristin; JAKUBZICK, Claudia et al.The American journal of pathology. 2007, Vol 170, Num 4, pp 1152-1164, issn 0002-9440, 13 p.Article

Towards a ligand targeted enzyme prodrug therapy : Single round panning of a β-lactamase scaffold library on human cancer cellsSHUKIA, Girja S; MURRAY, Christopher J; ESTABROOK, Melodie et al.International journal of cancer. 2007, Vol 120, Num 10, pp 2233-2242, issn 0020-7136, 10 p.Article

c-Met is a potentially new therapeutic target for treatment of human melanomaPURI, Neelu; AHMED, Salman; JANAMANCHI, Varalakshmi et al.Clinical cancer research. 2007, Vol 13, Num 7, pp 2246-2253, issn 1078-0432, 8 p.Article

Chimiothérapie des sarcomes des tissus mous métastatiques et localement avancés = Chemotherapy for metastatic and locally advanced soft tissue sarcomaLE CESNE, A; CIOFFI, A.Oncologie (Paris). 2007, Vol 9, Num 2, pp 114-125, issn 1292-3818, 12 p.Article

The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapyTORTORA, G; GELARDI, T; CIARDIELLO, F et al.The International journal of biological markers. 2007, Vol 22, Num 1, issn 0393-6155, S47-S52, SUP4Article

Future strategies for targeted therapies and tailored patient management in pancreatic cancerKO, Andrew H.Seminars in oncology. 2007, Vol 34, Num 4, pp 354-364, issn 0093-7754, 11 p.Article